These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 18299519

  • 1. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M, Kimura T, Kubota T, Matsumura T, Sumi H, Fujimura H, Takahashi MP, Sakoda S.
    Neurology; 2008 Feb 26; 70(9):677-85. PubMed ID: 18299519
    [Abstract] [Full Text] [Related]

  • 2. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
    Nakamori M, Kimura T, Fujimura H, Takahashi MP, Sakoda S.
    Muscle Nerve; 2007 Aug 26; 36(2):251-7. PubMed ID: 17487865
    [Abstract] [Full Text] [Related]

  • 3. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
    Savkur RS, Philips AV, Cooper TA.
    Nat Genet; 2001 Sep 26; 29(1):40-7. PubMed ID: 11528389
    [Abstract] [Full Text] [Related]

  • 4. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M, Ohsawa N, Kino Y, Sasagawa N, Nishino I, Ishiura S.
    Genes Cells; 2011 Sep 26; 16(9):961-72. PubMed ID: 21794030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy.
    Ohsawa N, Koebis M, Suo S, Nishino I, Ishiura S.
    Biochem Biophys Res Commun; 2011 May 27; 409(1):64-9. PubMed ID: 21549096
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
    Ho TH, Bundman D, Armstrong DL, Cooper TA.
    Hum Mol Genet; 2005 Jun 01; 14(11):1539-47. PubMed ID: 15843400
    [Abstract] [Full Text] [Related]

  • 9. The role of α-dystrobrevin in striated muscle.
    Nakamori M, Takahashi MP.
    Int J Mol Sci; 2011 Jun 01; 12(3):1660-71. PubMed ID: 21673914
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR.
    Storbeck CJ, Drmanic S, Daniel K, Waring JD, Jirik FR, Parry DJ, Ahmed N, Sabourin LA, Ikeda JE, Korneluk RG.
    Hum Mol Genet; 2004 Mar 15; 13(6):589-600. PubMed ID: 14734627
    [Abstract] [Full Text] [Related]

  • 11. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG, Butler TL, Egan JR, Cooper ST, Lo HP, Compton AG, North KN, Winlaw DS.
    Acta Neuropathol; 2008 Sep 15; 116(3):235-46. PubMed ID: 18392839
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine-phosphorylated and nonphosphorylated isoforms of alpha-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions.
    Grady RM, Akaaboune M, Cohen AL, Maimone MM, Lichtman JW, Sanes JR.
    J Cell Biol; 2003 Mar 03; 160(5):741-52. PubMed ID: 12604589
    [Abstract] [Full Text] [Related]

  • 13. Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.
    de León MB, Cisneros B.
    J Neurosci Res; 2008 Jan 03; 86(1):18-26. PubMed ID: 17549748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pathogenesis of myotonic dystrophy type 1].
    Magaña JJ, Leyva-García N, Cisneros B.
    Gac Med Mex; 2009 Jan 03; 145(4):331-7. PubMed ID: 20073433
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
    Frisch R, Singleton KR, Moses PA, Gonzalez IL, Carango P, Marks HG, Funanage VL.
    Mol Genet Metab; 2001 Jan 03; 74(1-2):281-91. PubMed ID: 11592825
    [Abstract] [Full Text] [Related]

  • 20. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase.
    Thomas GD, Shaul PW, Yuhanna IS, Froehner SC, Adams ME.
    Circ Res; 2003 Mar 21; 92(5):554-60. PubMed ID: 12600881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.